
STAT Plus: Pharmalittle: Buttigieg wants pharma to ‘thrive’; U.S. patent panel boosts Biogen, disappoints Gilead
Rise and shine, everyone, another busy day is on the way. We can tell because…

Rise and shine, everyone, another busy day is on the way. We can tell because…